234 related articles for article (PubMed ID: 18685488)
1. Vascular and lymphatic properties of the superficial and deep lamina propria in Barrett esophagus.
Hahn HP; Shahsafaei A; Odze RD
Am J Surg Pathol; 2008 Oct; 32(10):1454-61. PubMed ID: 18685488
[TBL] [Abstract][Full Text] [Related]
2. Muscularis mucosae duplication and the musculo-fibrous anomaly in endoscopic mucosal resections for barrett esophagus: implications for staging of adenocarcinoma.
Lewis JT; Wang KK; Abraham SC
Am J Surg Pathol; 2008 Apr; 32(4):566-71. PubMed ID: 18300796
[TBL] [Abstract][Full Text] [Related]
3. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT
Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229
[TBL] [Abstract][Full Text] [Related]
4. Effect of tumor characteristics and duplication of the muscularis mucosae on the endoscopic staging of superficial Barrett esophagus-related neoplasia.
Mandal RV; Forcione DG; Brugge WR; Nishioka NS; Mino-Kenudson M; Lauwers GY
Am J Surg Pathol; 2009 Apr; 33(4):620-5. PubMed ID: 19047893
[TBL] [Abstract][Full Text] [Related]
5. Treatment of Barrett's esophagus with high-grade dysplasia and intramucosal adenocarcinoma.
Zehetner J; DeMeester SR
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):493-8. PubMed ID: 19817671
[TBL] [Abstract][Full Text] [Related]
6. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor and basic fibroblast growth factor expression in esophageal adenocarcinoma and Barrett esophagus.
Lord RV; Park JM; Wickramasinghe K; DeMeester SR; Oberg S; Salonga D; Singer J; Peters JH; Danenberg KD; Demeester TR; Danenberg PV
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):246-53. PubMed ID: 12579092
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical staining for smoothelin in the duplicated versus the true muscularis mucosae of Barrett esophagus.
Faragalla HF; Marcon NE; Yousef GM; Streutker CJ
Am J Surg Pathol; 2011 Jan; 35(1):55-9. PubMed ID: 21164287
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of the duplicated muscularis mucosae in Barrett esophagus-related superficial adenocarcinoma.
Kaneshiro DK; Post JC; Rybicki L; Rice TW; Goldblum JR
Am J Surg Pathol; 2011 May; 35(5):697-700. PubMed ID: 21490446
[TBL] [Abstract][Full Text] [Related]
10. Esophageal submucosa: the watershed for esophageal cancer.
Raja S; Rice TW; Goldblum JR; Rybicki LA; Murthy SC; Mason DP; Blackstone EH
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1403-11.e1. PubMed ID: 22093714
[TBL] [Abstract][Full Text] [Related]
11. Total endoscopic eradication of Barrett's esophagus: study methodology, candidate selection, and clinical outcomes.
Shaheen NJ; Spechler SJ
Endoscopy; 2008 Dec; 40(12):994-9. PubMed ID: 19065482
[No Abstract] [Full Text] [Related]
12. Targeting surveillance in Barrett's esophagus.
Hillman L
J Gastroenterol Hepatol; 2008 Sep; 23(9):1311-2. PubMed ID: 18853989
[No Abstract] [Full Text] [Related]
13. Lymphatic invasion according to D2-40 immunostaining is a strong predictor of nodal metastasis in superficial squamous cell carcinoma of the esophagus: algorithm for risk of nodal metastasis based on lymphatic invasion.
Tomita N; Matsumoto T; Hayashi T; Arakawa A; Sonoue H; Kajiyama Y; Tsurumaru M
Pathol Int; 2008 May; 58(5):282-7. PubMed ID: 18429826
[TBL] [Abstract][Full Text] [Related]
14. The future of endoscopic treatment of early Barrett neoplasia: the endoscopist's view.
Falk GW
Endoscopy; 2008 Dec; 40(12):1041-7. PubMed ID: 19065489
[No Abstract] [Full Text] [Related]
15. Invasion of poorly differentiated adenocarcinoma to the deep muscularis mucosae may be an indicator of lymph node metastasis in Barrett's esophageal cancer.
Sakaguchi Y; Ono S; Fujishiro M; Yamamichi N; Koike K
Dig Endosc; 2013 May; 25 Suppl 2():168-72. PubMed ID: 23617671
[TBL] [Abstract][Full Text] [Related]
16. Subepithelial extension of squamous cell carcinoma in the esophagus: histopathological study using D2-40 immunostaining for 108 superficial carcinomas.
Amano T; Matsumoto T; Hayashi T; Arakawa A; Sonoue H; Kajiyama Y; Tsurumaru M
Pathol Int; 2007 Dec; 57(12):759-64. PubMed ID: 17988276
[TBL] [Abstract][Full Text] [Related]
17. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
Hosono I; Miyahara R; Furukawa K; Funasaka K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Yokoi T; Tsukamoto T; Hirooka Y; Fujishiro M
BMC Gastroenterol; 2020 Jun; 20(1):175. PubMed ID: 32503448
[TBL] [Abstract][Full Text] [Related]
18. Esophageal polypoid dysplasia of gastric foveolar phenotype with focal intramucosal carcinoma associated with Barrett's esophagus.
Asthana N; Mandich D; Ligato S
Am J Surg Pathol; 2008 Oct; 32(10):1581-5. PubMed ID: 18724240
[TBL] [Abstract][Full Text] [Related]
19. [Early esophageal carcinoma: diagnosis and endoscopic therapy].
Ell C
Z Gastroenterol; 2002 Dec; 40 Suppl 2():12-4. PubMed ID: 12466997
[No Abstract] [Full Text] [Related]
20. Future developments in total Barrett's eradication: the surgeon's view.
Watson TJ; Peters JH
Endoscopy; 2008 Dec; 40(12):1048-51. PubMed ID: 19065490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
